Insider Transactions in Q1 2025 at Elevance Health, Inc. (ELV)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 05
2025
|
Charles Morgan Kendrick Jr EVP & President, Commercial |
SELL
Open market or private sale
|
Direct |
3,504
-25.73%
|
$1,387,584
$396.3 P/Share
|
|
Mar 03
2025
|
Charles Morgan Kendrick Jr EVP & President, Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
6,531
+21.78%
|
-
|
|
Mar 03
2025
|
Charles Morgan Kendrick Jr EVP & President, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
2,221
-23.86%
|
$877,295
$395.5 P/Share
|
|
Mar 03
2025
|
Ronald W Penczek CAO & Controller |
BUY
Grant, award, or other acquisition
|
Direct |
706
+14.38%
|
-
|
|
Mar 03
2025
|
Ronald W Penczek CAO & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
198
-11.11%
|
$78,210
$395.5 P/Share
|
|
Mar 03
2025
|
Felicia F Norwood EVP & President,Gov Health Ben |
BUY
Grant, award, or other acquisition
|
Direct |
7,248
+10.76%
|
-
|
|
Mar 03
2025
|
Felicia F Norwood EVP & President,Gov Health Ben |
SELL
Payment of exercise price or tax liability
|
Direct |
2,613
-9.57%
|
$1,032,135
$395.5 P/Share
|
|
Mar 03
2025
|
Ratnakar Lavu EVP, Chief Digital & Info Off |
BUY
Grant, award, or other acquisition
|
Direct |
2,339
+32.84%
|
-
|
|
Mar 03
2025
|
Ratnakar Lavu EVP, Chief Digital & Info Off |
SELL
Payment of exercise price or tax liability
|
Direct |
312
-11.32%
|
$123,240
$395.5 P/Share
|
|
Mar 03
2025
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
BUY
Grant, award, or other acquisition
|
Direct |
7,248
+13.08%
|
-
|
|
Mar 03
2025
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
SELL
Payment of exercise price or tax liability
|
Direct |
2,281
-10.84%
|
$900,995
$395.5 P/Share
|
|
Mar 03
2025
|
Gail Boudreaux President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
26,207
+8.79%
|
-
|
|
Mar 03
2025
|
Gail Boudreaux President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,396
-8.2%
|
$4,106,420
$395.5 P/Share
|
|
Mar 03
2025
|
Mark Kaye EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
3,604
+13.27%
|
-
|
|
Mar 03
2025
|
Mark Kaye EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
270
-1.33%
|
$106,650
$395.5 P/Share
|
|
Jan 03
2025
|
Blair Williams Todt EVP, CLO & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
398
-2.48%
|
$147,658
$371.56 P/Share
|